ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
NCT ID: NCT00545610
Last Updated: 2018-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2007-10-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
NCT01508910
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction
NCT00874354
Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI
NCT00711542
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
NCT05711849
Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
NCT00313339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test 1 (n=50)
1 x 10\^5 (+/-10%) CD34+ cells/kg of body weight
No interventions assigned to this group
Test 2 (n=50)
5 x 10\^5 (+/-10%) CD34+ cells/kg of body weight
No interventions assigned to this group
Placebo (n=50)
Saline plus 5% autologous plasma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who are willing to comply with the specified follow-up evaluations in this study and to provide written informed consent to participate in this study
21 Years
81 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lisata Therapeutics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caladrius Study Director
Role: STUDY_DIRECTOR
Lisata Therapeutics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology, PC
Birmingham, Alabama, United States
Mayo Clinic Hospital
Phoenix, Arizona, United States
Scripps Green Hospital / Scripps Clinical Hospital
La Jolla, California, United States
Stanford University Hospital and Clinics
Stanford, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Holy Cross Hospital
Fort Lauderdale, Florida, United States
University of Florida
Gainesville, Florida, United States
University of Florida Health Science Center
Jacksonville, Florida, United States
Cardiovascular Institute Florida Hospital
Orlando, Florida, United States
The Medical Group of St. Joseph´s
Atlanta, Georgia, United States
Northwestern University Medical School
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Iowa
Iowa City, Iowa, United States
Caritas St. Elizabeth´s Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Cornell University
New York, New York, United States
New York Presbyterian Hospital
New York, New York, United States
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University of Wisconsin Medical School
Madison, Wisconsin, United States
Heart Care Associates, LLC
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34976
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.